Results 331 to 340 of about 496,062 (355)

Dexamethasone for COVID-19? Not so fast.

Journal of Biological Regulators and Homeostatic Agents, 2020
Recent announcements indicated, without sharing any distinct published set of results, that the corticosteroid dexamethasone may reduce mortality of severe COVID-19 patients only.
T. C. Theoharides, Peter S. Conti
semanticscholar   +1 more source

Perineural and intravenous dexamethasone and dexmedetomidine: network meta‐analysis of adjunctive effects on supraclavicular brachial plexus block

Anaesthesia, 2020
Both perineural and intravenous dexamethasone and dexmedetomidine are used as local anaesthetic adjuncts to enhance peripheral nerve block characteristics.
Herman Sehmbi, R. Brull, K. R. Ceballos, U. J. Shah, Janet Martin, A. Tobías, K. Solo, F. Abdallah   +7 more
semanticscholar   +1 more source

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.

The Lancet Respiratory Medicine, 2020
J. Villar, C. Ferrando, Domingo Martínez, A. Ambrós, T. Muñoz, J. Soler, G. Aguilar, Francisco Alba, E. González-Higueras, Luís A Conesa, C. Martín-Rodríguez, F. Díaz-Domínguez, Pablo Serna-Grande, R. Rivas, J. Ferreres, J. Belda, L. Capilla, Alec Tallet, J. Añón, R. L. Fernández, J. González-Martín   +20 more
semanticscholar   +1 more source

Statistical review of Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

, 2020
T. Morris, Darren Dahly, K. Hood, S. Gates   +3 more
semanticscholar   +1 more source

Dexamethasone in Hospitalized Patients with Covid-19

New England Journal of Medicine, 2021
Peter W Horby, Wei Shen Lim, Jonathan R Emberson   +2 more
exaly  

Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review

SN Comprehensive Clinical Medicine, 2020
Mukhtar H Ahmed
exaly  

Background to new treatments for COVID‐19, including its chronicity, through altering elements of the cytokine storm

Reviews in Medical Virology, 2021
Ian A Clark
exaly  

Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems

ACS Biomaterials Science and Engineering, 2022
Vijay Sagar Madamsetty, Reza Mohammadinejad, Noushin Nabavi   +2 more
exaly  

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Ophthalmology, 2014
Young Hee Yoon, Rubens Belfort Jr, Francesco M Bandello   +2 more
exaly